Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

3 Things About AT&T That Smart Investors Know


If you've been an AT (NYSE: T) shareholder for some years now, I'm sure I don't have to tell you how turbulent a ride it has been. The telecom giant is down by more than 34% in the past three years, due to a handful of missteps by company management and a pessimistic outlook among investors.

With its stock hovering near a 52-week low, it may be tempting to lose faith in the telecom giant. However, before writing the company off, here are three things to consider.

Like other telecom stocks, AT doesn't typically attract investors for its share price growth potential. It's all about the dividend. AT's quarterly payout is $0.28 per share. AT the current share price, that gives it a trailing 12-month yield of around 7.5%.

Continue reading


Source Fool.com

Allergy Therapeutics PLC Aktie

0,051 €
3,06 %
Heute geht es für Allergy Therapeutics PLC stark aufwärts mit einem Zuwachs von 3,06 %.

Like: 0
T
Teilen

Kommentare